期刊文献+

达英与二甲双胍联合对胰岛素抵抗合并多囊卵巢综合征患者临床疗效探究 被引量:3

Clinical Efficacy of Patients with Polycystic Ovary Syndrome Combined with Insulin Resistance Treated with Diane and Metformin
下载PDF
导出
摘要 目的:探讨达英与二甲双胍联合对胰岛素抵抗合并多囊卵巢综合征(PCOS)患者的临床疗效,为临床提供参考。方法:选择笔者所在医院收治的84例PCOS患者,将所有患者随机分为A、B、C组,各28例。A、B、C组患者分别以二甲双胍、达英-35、二甲双胍联合达英-35服用。观察三组患者治疗前、治疗后的卵巢体积、卵泡刺激素(FSH)等指标。结果:A组治疗前后的卵巢体积、T、FINS、FPG及HOMA-IR比较,差异均有统计学意义(t=2.586、5.737、10.239、3.548、9.189,P<0.05)。B组治疗前后的卵巢体积、LH、T、FINS、FPG及HOMA-IR比较,差异均有统计学意义(t=2.564、4.921、19.411、10.532、2.842、12.558,P<0.05)。C组治疗前后的卵巢体积、LH、FSH、T、FINS、FPG及HOMA-IR比较,差异均有统计学意义(t=2.561、7.070、4.257、34.610、12.720、6.623、20.805,P<0.05)。三组患者的卵巢体积、LH、T、HOMA-IR指标比较,差异均有统计学意义(Z=6.281、7.328、6.820、6.829,P<0.05)。三组月经恢复率、排卵率及妊娠率比较差异均有统计学意义(字2=12.349、6.921、5.927,P<0.05)。结论:二甲双胍联合达英-35对于胰岛素抵抗合并多囊卵巢综合征疗效显著。 Objective:To investigate the clinical efficacy of patients with polycystic ovary syndrome combined with insulin resistance treated with Diane and Metformin.Method:84 patients with polycystic ovary syndrome combined with insulin resistance were chosen in our hospital to receive treatment,they were divided into three groups,28 patients in each group.The group A,group B and group C were treated with Metformin,Diane-35,Diane-35 combined with Metformin.The ovarian volume,follicle stimulating hormone(FSH) and other indicators in three groups of patients before and after treatment were observed.Result:Before and after treatment,the ovarian volume,T,FINS,FPG and HOMA-IR of group A were compared,the differences were statistically significant(t=2.586,5.737,10.239,3.548,9.189,P〈0.05).Before and after treatment,the ovarian volume,LH,T,FINS,FPG and HOMA-IR of group B were compared,the differences were statistically significant(t=2.564,4.921,19.411,10.532,2.842,12.558,P〈0.05).Before and after treatment,the ovarian volume,LH,FSH,T,FINS,FPG and HOMA-IR of group C were compared,the differences was statistically significant(t=2.561,7.070,4.257,34.610,12.720,6.623,20.805,P〈0.05).The ovarian volume,LH,T,HOMA-IR index of three groups,the differences were statistically significant(Z=6.281,7.328,6.820,6.829,P〈0.05).There were statistical differences in the recovery rate of menstruation,ovulation rate and pregnancy rate among the three groups(χ^2=12.349,6.921,5.927,P〈0.05).Conclusion:The efficacy of insulin resistance in polycystic ovary syndrome treated with Diane-35 combined with Metformin is significant.
机构地区 丰顺县人民医院
出处 《中外医学研究》 2015年第2期12-14,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 达英 二甲双胍 胰岛素抵抗 多囊卵巢综合征 Diane Metformin Insulin resistance Polycystic ovary syndrome
  • 相关文献

参考文献15

  • 1Fauser B C, Tarlatzis B C, Rebar R W, ct al.Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group[J].Fertll Steril, 2012, 97(1): 28-38.
  • 2DeGroot P C, Dekkers O M, Romijn J A, et al.PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis[J].Hum Reprod Update, 2011, 17(4):495-500,.
  • 3Manneras-Holm L, Leonhardt H, Kullberg J, et al.Adipose tigaue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance[J].J Clin Endocrinol Metab, 2011, 96(2): 304- 311.
  • 4Jakubowicz D, Barnea M, Wainstein J, et al.Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome[J].Clin Sci Lond, 2013, 125(9):423-432.
  • 5张建伟,何泓.多囊卵巢综合征导致不孕的危险因素及治疗方案探讨[J].海南医学,2014,25(12):1750-1753. 被引量:21
  • 6周丽英.多囊卵巢综合征的诊断与治疗[J].中国医学创新,2013,10(36):106-108. 被引量:15
  • 7杨军.不同药物治疗多囊卵巢综合征的疗效分析[J].中国医学创新,2014,11(16):35-38. 被引量:14
  • 8Anderson A D, Solorzano C M, McCartney C R.Childhood obesity and its impact on the development of adolescent PCOS[J].Semin Reprod Med, 2014, 32(3): 202-213.
  • 9Hoeger K M, Legro R S, Welt C K.A patient's guide: polycystic ovary syndrome(PCOS)[J].J Clin Endocrinol Metab, 2014, 99(1); 35-36.
  • 10Rey-Roldan E, Perez Lana M B, Galluzzo L, et al.ls the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolicrisk[J].GynecolEndocrinol, 2013, 29(2): 141-144.

二级参考文献76

  • 1杨冬梓,冯淑英,李琳,陈晓莉,赵晓苗,陈亚肖.青春期多囊卵巢综合征[J].现代妇产科进展,2006,15(10):721-734. 被引量:23
  • 2乔杰.多囊卵巢综合征[M].北京:北京大学医学出版社,2010.190.
  • 3Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus WorkshopGroup. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystie ovary syndrome [ J ] . Hum Reprod, 2004, 81 ( 1 ) : 19-25.
  • 4Coolman M, de Groot CJ, Sreegers EA, et al. Concentrations of plasminogen activators and their inhibitors in blood preeonceptionally, during and after pregnancy [ J ] . Eur J Obstet Gynecol Reprod Biol, 2006, 128 ( 1/2 ) : 22-28.
  • 5Brenner B. Haemostatie changes in pregnancy [ J] . Thromh Res, 2004, 114 (5-6) : 409-414.
  • 6Lindholm A, Bixo M, Eliasson M, et al. Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome [ J ]. Gynecol Endocrinol, 2010, 26 ( 10 ): 743-748.
  • 7Kjerulff LE, Sanehez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome : a metaanalysis [ J ] . Am J Obstet Gvnecol, 2011, 204 ( 6 ) : 558.e1-558.e6.
  • 8Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism [ J ] . N Engl J Med, 2000, 343 ( 7 ) : 457-462.
  • 9Gerrits AJ, Koekman CA, van Haeften TW, et al. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin [ J ] . Diabetes, 2010, 59 ( 6 ) : 1487-1495.
  • 10Klovaite J, Benn M, Yazdanyar S, et al. High platelet volume and increased risk of myocardial infarction : 39, 531 participants from the general population [ J ] . J Thromb Haemost, 2011,9 ( 1 ) : 49-56.

共引文献56

同被引文献41

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部